Skip to Content Julius Bär

Tracker Certificate on the Digital Health Basket 2019

The political rhetoric around fundamental healthcare reform in the United States has recently increased as the Democratic primary contest is heating up. Several contenders for the White House are advocating fundamental reform to the way healthcare is provided in the United States.

In this environment, medical technology and life-science tool companies are our favoured sub-groups within healthcare. They should be impacted less by any fundamental reforms than other sub-groups within the sector.

Medical technology and life-science tool companies are well positioned for the future given their use of digital technology, which can contribute to innovation and cost savings and thus reduce the overall financial burden of many households. This is important in the context of rising healthcare costs driven by an ageing population and a rise in chronic diseases.

In addition, digital technology in the healthcare industry can help improve healthcare-related services in terms of prevention, diagnosis and treatment.

Investors looking to gain exposure to companies who will shape the digitisation of the healthcare industry could consider investing in the Julius Baer Tracker Certificate on the Digital Health Basket 2019. This tracker certificate is currently in subscription and allows investors to fully participate in the performance of the underlying basket, which consists of the following 8 stocks:

  1. Danaher Corp
  2. QIAGEN NV
  3. Johnson & Johnson
  4. Zimmer Biomet Holdings Inc
  5. Merck KGaA
  6. Abbott Laboratories
  7. Boston Scientific Corp
  8. Thermo Fisher Scientific Inc
Back to top